Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters

Abstract

Background:

Chemotactic cytokines, referred to as chemokines, play an important role in leukocyte trafficking. The circulating levels of chemokines have been shown to increase in inflammatory processes including obesity-related pathologies (e.g. atherosclerosis and diabetes). However, little is currently known about the relationship between chemokines and human obesity. In the present study, we investigated the circulating levels of selected chemokines (monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α), leukotactin-1, interleukin-8 (IL-8)) and the association between the chemokine levels and obesity-related parameters: body mass index (BMI), waist circumference, fasting glucose and insulin levels, lipids profile, and the level of C-reactive protein (CRP).

Methods:

A total of 100 subjects, 50 obese (BMI25 kg/m2) and 50 who were not obese (BMI<25 kg/m2) participated in the present study. The levels of chemokines and CRP were measured in a fasting state serum by sandwich enzyme-linked immunosorbent assay. Total cholesterol, high-density lipoprotein (HDL)-cholesterol, triglyceride, glucose, and insulin levels were measured by enzymatic analysis and immunoassay.

Results:

The circulating levels of MCP-1 and IL-8 in the serum were significantly (P<0.05) higher in obese subjects (BMI>30 kg/m2) compared with those of nonobese controls (BMI<25 kg/m2). The levels of CRP were positively correlated with BMI (P<0.001) or waist circumference (P<0.0001). The levels of MCP-1 and IL-8 were positively related to BMI (MCP-1, P<0.02; IL-8, P<0.01) and/or waist circumference (MCP-1, P<0.009; IL-8, P<0.03). The levels of MCP-1 were positively related to the levels of CRP (P<0.007) or interleukin-6 (IL-6) (P<0.0001), and negatively related to the levels of HDL-cholesterol (P<0.01). Homeostasis model assessment (HOMA) score was positively related to the levels of MCP-1 (P<0.02) or IL-8 (P<0.03) in obese subject.

Discussion:

Our data demonstrated that the circulating levels of MCP-1 and IL-8 are related to obesity-related parameters such as BMI, waist circumference, CRP, IL-6, HOMA and HDL-cholesterol. These findings suggest that the circulating MCP-1 and/or IL-8 may be a potential candidate linking obesity with obesity-related metabolic complications such as atherosclerosis and diabetes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Das UN . Is obesity an inflammatory condition? Nutrition 2001; 17: 953–966.

    Article  CAS  PubMed  Google Scholar 

  2. Ross R . Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 115–126.

    Article  CAS  PubMed  Google Scholar 

  3. Dandona P, Aljada A, Chaudhuri A, Mohanty P . Endothelial dysfunction, inflammation and diabetes. Rev Endocr Metab Disord 2004; 5: 189–197.

    Article  CAS  PubMed  Google Scholar 

  4. Lyon CJ, Law RE, Hsueh WA . Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003; 144: 2195–2200.

    Article  CAS  PubMed  Google Scholar 

  5. Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB . Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 2001; 157: 495–503.

    Article  CAS  PubMed  Google Scholar 

  6. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G . Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: E745–E751.

    Article  CAS  PubMed  Google Scholar 

  7. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB . Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131–2135.

    Article  CAS  PubMed  Google Scholar 

  8. Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004; 28: 993–997.

    Article  CAS  PubMed  Google Scholar 

  9. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD . Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001; 175: 81–92.

    Article  CAS  PubMed  Google Scholar 

  10. Kim CS, Kawada T, Yoo H, Kwon BS, Yu R . Macrophage inflammatory protein-related protein-2, a novel CC chemokine, can regulate preadipocyte migration and adipocyte differentiation. FEBS Lett 2003; 548: 125–130.

    Article  CAS  PubMed  Google Scholar 

  11. Sartipy P, Loskutoff DJ . Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci 2003; 100: 7265–7270.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821–1830.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Reape TJ, Groot PH . Chemokines and atherosclerosis. Atherosclerosis 1999; 147: 213–225.

    Article  CAS  PubMed  Google Scholar 

  14. Yu R, Kim CS, Kawada T, Kwon TW, Lim TH, Kim YW et al. Involvement of leukotactin-1, a novel CC chemokine, in human atherosclerosis. Atherosclerosis 2004; 174: 35–42.

    Article  CAS  PubMed  Google Scholar 

  15. Bruun JM, Lihn AS, Madan AK, Pedersen SB, Schiøtt KM, Fain JN et al. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab 2004; 286: E8–E13.

    Article  CAS  PubMed  Google Scholar 

  16. Straczkowski M, Dzienis-Straczkowska S, Stepien A, Kowalska I, Szelachowska M, Kinalska I . Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 2002; 87: 4602–4606.

    Article  CAS  PubMed  Google Scholar 

  17. World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. World Heath Organization: Geneva, Switzerland, 2000.

  18. Friedewald WT, Levy RI, Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 488–502.

    Google Scholar 

  19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.

    Article  CAS  PubMed  Google Scholar 

  20. Christiansen T, Richelsen B, Bruun JM . Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes Relat Metab Disord 2005; 29: 146–150.

    Article  CAS  Google Scholar 

  21. Bruun JM, Pedersen SB, Richelsen B . Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 2001; 86: 1267–1273.

    CAS  PubMed  Google Scholar 

  22. Takahashi K, Mizuarai S, Araki H, Mashiko S, Ishihara A, Kanatani A et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 2003; 278: 46654–46660.

    Article  CAS  PubMed  Google Scholar 

  23. Sheikine Y, Hansson GK . Chemokines and atherosclerosis. Ann Med 2004; 36: 98–118.

    Article  CAS  PubMed  Google Scholar 

  24. Kunkel SL, Godessart N . Chemokines in autoimmunity: from pathology to therapeutics. Autoimmun Rev 2002; 1: 313–320.

    Article  CAS  PubMed  Google Scholar 

  25. Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999; 19: 1986–1991.

    Article  CAS  PubMed  Google Scholar 

  26. Ridker PM, Hennekens CH, Buring JE, Rifai N . C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836–843.

    Article  CAS  PubMed  Google Scholar 

  27. Forouhi NG, Sattar N, McKeigue PM . Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001; 25: 1327–1331.

    Article  CAS  PubMed  Google Scholar 

  28. Devaraj S, Kumaresan PR, Jialal I . Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J Mol Cell Cardiol 2004; 36: 405–410.

    Article  CAS  PubMed  Google Scholar 

  29. Zozulinska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B . Serum interleukin-8 level is increased in diabetic patients. Diabetologia 1999; 42: 117–118.

    Article  CAS  PubMed  Google Scholar 

  30. Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B . Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol 2003; 148: 535–542.

    Article  CAS  PubMed  Google Scholar 

  31. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone Jr MA et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999; 398: 718–723.

    Article  CAS  PubMed  Google Scholar 

  32. Lee WY, Park JS, Noh SY, Rhee EJ, Sung KC, Kim BS et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol 2004; 97: 101–106.

    Article  PubMed  Google Scholar 

  33. Blake GJ, Ridker PM . C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events. Arterioscler Thromb Vasc Biol 2002; 22: 1512–1513.

    Article  PubMed  Google Scholar 

  34. Lin SY, Wang YY, Sheu WH . Increased serum soluble tumor necrosis factor receptor levels are associated with insulin resistance in liver cirrhosis. Metabolism 2004; 53: 922–926.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a SRC Fund to IRC at the University of Ulsan, from the KOSEF and the Korean Ministry of Science and Technology, and by a grant from the University of Ulsan. HS Park was supported by a grant from Asan Institute for life Science 2002-106. T Kawada was supported by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15081205, 16380087).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Yu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, CS., Park, HS., Kawada, T. et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes 30, 1347–1355 (2006). https://doi.org/10.1038/sj.ijo.0803259

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803259

Keywords

This article is cited by

Search

Quick links